Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 54Unknown 9Terminated 7Withdrawn 3Recruiting 3Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Hematologic Neoplasms 1Epilepsy 1Digestive System Diseases 1Brain Neoplasms 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Fentanyl × Clear all
NCT03214510 2026-03-05

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
101 enrolled

Digestive System Diseases

NCT04188418 2026-02-19

Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting
88 enrolled
CNS

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡